We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:2245P Marchpole Holdings PLC 01 September 2003 Marchpole Holdings plc (the "Company") Results of AGM, EGM and Class Meeting Marchpole Holdings plc announces that all resolutions proposed at the Company's Annual General Meeting, Extraordinary General Meeting and class meeting of holders of Deferred Shares held today were duly passed. Accordingly, shareholders approved a proposed reduction of share capital of the Company by the cancellation of all 2,269,636,811 Deferred Shares in issue and reduction of amounts outstanding to the share premium account of the Company by #14,070,000 in order to eliminate in full the deficit on the Company's profit and loss account as at 31 March 2003. The proposed reduction of share capital and amounts outstanding to the share premium account remain conditional on the approval of the High Court. A further announcement will be made when a hearing date is set. 1 September 2003 This information is provided by RNS The company news service from the London Stock Exchange END AGMUAUAROBRKRAR
1 Year Mereo Biopharma Chart |
1 Month Mereo Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions